Komori
Kaken Pharmaceutical (4521) · InitiativeAdvanced

Introducing an Employee Stock Benefit Trust (J-ESOP)

First written in FY2026-H1. 1 of 2 entries say "Advanced", first in FY2026. Latest entry: FY2026.

2entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2026-H12025: 120252026: 12026
Same theme, other companies
Introduction of a Stock-Delivery Trust (J-ESOP)A theme 69 companies write about · 0 as a headwind · 70 as a tailwind

26 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 69 companies compared. The sentences above are computed from all 69.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Based on a resolution of the Board of Directors at its meeting held on 27 March 2025, the Company introduced the J-ESOP to more closely link employee compensation with the Company’s share price and performance, share economic benefits with shareholders, and increase employees’ motivation and morale to improve the share price and performance. Total number of shares scheduled to be acquired for employees: 110,000 shares」

    For the J-ESOP launched in FY2026-H1, the annual report provides details of the plan’s operation, including 110,000 shares scheduled to be delivered to employees and 110,000 shares held in trust.
  2. FY2026-H1First statedAnnual report

    「The Company began operating the J-ESOP, an incentive plan under which employees receive the Company’s shares, to more closely link employee compensation with the Company’s share price and performance, share economic benefits with shareholders, and increase employees’ motivation and morale to improve the share price and performance. The Company disposed of 110,000 treasury shares on 17 June 2025. The disposal of treasury shares was conducted in connection with the launch of the J-ESOP.」

    The Company began operating the J-ESOP to link employee compensation with the share price and performance, share economic benefits with shareholders, and increase employees’ motivation and morale to improve the share price and performance. On 17 June 2025, it disposed of 110,000 treasury shares. Under the plan, employees are granted points based on performance, individual contributions and other factors, and receive shares or other benefits.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Kaken Pharmaceutical's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.